Passive immunisation against respiratory syncytial virus: a cost-effectiveness analysis.

Rietveld, Edwin; Steyerberg, Ewout W; Polder, Johan J; Veeze, Henk J; Vergouwe, Yvonne; Huysman, Marianne Wa; de Groot, Ronald; Moll, Henriëtte A

Rietveld, Edwin; Steyerberg, Ewout W; Polder, Johan J; Veeze, Henk J; Vergouwe, Yvonne; Huysman, Marianne Wa; de Groot, Ronald; Moll, Henriëtte A.

Affiliation

Rietveld E; Department of Pediatrics, Erasmus MC-Sophia, Rotterdam 3000 CB, the Netherlands.

Arch Dis Child ; 95(7): 493-8, 2010 Jul.

Article in En | MEDLINE | ID: mdl-20504841

Subject(s)

Immunization, Passive/economics; Respiratory Syncytial Virus Infections/prevention & control; Antibodies, Monoclonal/economics; Antibodies, Monoclonal/therapeutic use; Antibodies, Monoclonal, Humanized; Antiviral Agents/economics; Antiviral Agents/therapeutic use; Cost of Illness; Cost-Benefit Analysis; Drug Costs/statistics & numerical data; Female; Health Services Research/methods; Hospital Costs/statistics & numerical data; Hospitalization/statistics & numerical data; Humans; Immunization, Passive/methods; Infant; Infant, Newborn; Male; Netherlands/epidemiology; Palivizumab; Respiratory Syncytial Virus Infections/economics; Respiratory Syncytial Virus Infections/epidemiology; Seasons; Sensitivity and Specificity

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunization, Passive / Respiratory Syncytial Virus Infections Type of study: Diagnostic_studies / Health_economic_evaluation Limits: Female / Humans / Infant / Male / Newborn Country/Region as subject: Europa Language: En Journal: Arch Dis Child Year: 2010 Type: Article Affiliation country: Netherlands

Fulltext

XML

PubMed Links

Search on Google